These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33994068)

  • 1. Systematic review and meta-analysis of observational studies on BD-IPMNS progression to malignancy.
    Balduzzi A; Marchegiani G; Pollini T; Biancotto M; Caravati A; Stigliani E; Burelli A; Bassi C; Salvia R
    Pancreatology; 2021 May; ():. PubMed ID: 33994068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of branch-duct intraductal papillary mucinous neoplasms: a large single-center study to assess predictors of malignancy and long-term outcomes.
    Ridtitid W; DeWitt JM; Schmidt CM; Roch A; Stuart JS; Sherman S; Al-Haddad MA
    Gastrointest Endosc; 2016 Sep; 84(3):436-45. PubMed ID: 26905937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term Risk of Pancreatic Malignancy in Patients With Branch Duct Intraductal Papillary Mucinous Neoplasm in a Referral Center.
    Pergolini I; Sahora K; Ferrone CR; Morales-Oyarvide V; Wolpin BM; Mucci LA; Brugge WR; Mino-Kenudson M; Patino M; Sahani DV; Warshaw AL; Lillemoe KD; Fernández-Del Castillo C
    Gastroenterology; 2017 Nov; 153(5):1284-1294.e1. PubMed ID: 28739282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of Malignancy in "Pure" Branch-Duct Intraductal Papillary Mucinous Neoplasm of the Pancreas without Enhancing Mural Nodules on CT Imaging: A Nationwide Multicenter Study.
    Kim TH; Woo YS; Chon HK; Hwang JH; Yoo KS; Lee WJ; Lee KH; Lee JK; Dong SH; Park CH; Park ET; Moon JH; Kim HG; Cho KB; Kim HJ; Lee SO; Cheon YK; Lee JM; Park JW; Kim MH
    Gut Liver; 2018 Sep; 12(5):583-590. PubMed ID: 29730906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can the location of the mural nodule indicate benign or malignant in branch duct-type intraductal papillary mucinous neoplasm of the pancreas?
    Niiya F; Ohike N; Norose T; Takano Y; Azami T; Kobayashi T; Maruoka N; Wakabayashi T; Matsuo K; Tanaka K; Nagahama M
    Pancreatology; 2020 Oct; 20(7):1379-1385. PubMed ID: 32873485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the guidelines for management of pancreatic branch-duct intraductal papillary mucinous neoplasm.
    Tang RS; Weinberg B; Dawson DW; Reber H; Hines OJ; Tomlinson JS; Chaudhari V; Raman S; Farrell JJ
    Clin Gastroenterol Hepatol; 2008 Jul; 6(7):815-9; quiz 719. PubMed ID: 18602036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nomogram to predict malignancy in branch duct type intraductal papillary mucinous neoplasms.
    Xu Y; Xie C; Gao Z; Zhang M; Zhan M
    Medicine (Baltimore); 2022 Sep; 101(38):e30627. PubMed ID: 36197166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic main-duct involvement in branch-duct IPMNs: an underestimated risk.
    Fritz S; Klauss M; Bergmann F; Strobel O; Schneider L; Werner J; Hackert T; Büchler MW
    Ann Surg; 2014 Nov; 260(5):848-55; discussion 855-6. PubMed ID: 25379856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Trivial" Cysts Redefine the Risk of Cancer in Presumed Branch-Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Potential Target for Follow-Up Discontinuation?
    Marchegiani G; Andrianello S; Pollini T; Caravati A; Biancotto M; Secchettin E; Bonamini D; Malleo G; Bassi C; Salvia R
    Am J Gastroenterol; 2019 Oct; 114(10):1678-1684. PubMed ID: 31449158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid Growth Rates of Suspected Pancreatic Cyst Branch Duct Intraductal Papillary Mucinous Neoplasms Predict Malignancy.
    Kwong WT; Lawson RD; Hunt G; Fehmi SM; Proudfoot JA; Xu R; Giap A; Tang RS; Gonzalez I; Krinsky ML; Savides TJ
    Dig Dis Sci; 2015 Sep; 60(9):2800-6. PubMed ID: 25924899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of malignancy in pure branch duct type intraductal papillary mucinous neoplasm of the pancreas: A nationwide multicenter study.
    Kim TH; Song TJ; Hwang JH; Yoo KS; Lee WJ; Lee KH; Dong SH; Park CH; Park ET; Moon JH; Kim HG; Kim EY; Cho KB; Kim HJ; Lee SO; Cheon YK; Lee JM; Oh DW; Kim MH
    Pancreatology; 2015; 15(4):405-10. PubMed ID: 25998516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver transplant patients have a risk of progression similar to that of sporadic patients with branch duct intraductal papillary mucinous neoplasms.
    Lennon AM; Victor D; Zaheer A; Ostovaneh MR; Jeh J; Law JK; Rezaee N; Molin MD; Ahn YJ; Wu W; Khashab MA; Girotra M; Ahuja N; Makary MA; Weiss MJ; Hirose K; Goggins M; Hruban RH; Cameron A; Wolfgang CL; Singh VK; Gurakar A
    Liver Transpl; 2014 Dec; 20(12):1462-7. PubMed ID: 25155689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A resected case of two branch duct-type intraductal papillary mucinous neoplasms showing different clinical courses after a two-year follow-up.
    Shibata H; Ohike N; Norose T; Isobe T; Suzuki R; Imai H; Shiokawa A; Takimoto M; Tabuchi A; Takano Y; Yamamura E; Nagahama M; Takeyama N; Yokomizo K; Mizukami H; Tanaka JI; Aoki T; Murakami M
    Clin J Gastroenterol; 2017 Jun; 10(3):274-278. PubMed ID: 28258561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of malignancy in branch duct intraductal papillary mucinous neoplasm of the pancreas.
    Kawada N; Uehara H; Nagata S; Tsuchishima M; Tsutsumi M; Tomita Y
    JOP; 2014 Sep; 15(5):459-64. PubMed ID: 25262713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management and outcomes of intraductal papillary mucinous neoplasms.
    Hipp J; Mohamed S; Pott J; Sick O; Makowiec F; Hopt UT; Fichtner-Feigl S; Wittel UA
    BJS Open; 2019 Aug; 3(4):490-499. PubMed ID: 31388641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of age, comorbidities and relevant changes on surveillance strategy of intraductal papillary mucinous neoplasms: a competing risk analysis.
    Crippa S; Marchegiani G; Belfiori G; Rancoita PVM; Pollini T; Burelli A; Apadula L; Scarale MG; Socci D; Biancotto M; Vanella G; Arcidiacono PG; Capurso G; Salvia R; Falconi M
    Gut; 2024 Jul; 73(8):1336-1342. PubMed ID: 38653539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging Features for Predicting High-Grade Dysplasia or Malignancy in Branch Duct Type Intraductal Papillary Mucinous Neoplasm of the Pancreas: A Systematic Review and Meta-Analysis.
    Zhao W; Liu S; Cong L; Zhao Y
    Ann Surg Oncol; 2022 Feb; 29(2):1297-1312. PubMed ID: 34554343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyst features and risk of malignancy in intraductal papillary mucinous neoplasms of the pancreas: a meta-analysis.
    Anand N; Sampath K; Wu BU
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):913-21; quiz e59-60. PubMed ID: 23416279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thirty years of experience with intraductal papillary mucinous neoplasm of the pancreas: from discovery to international consensus.
    Tanaka M
    Digestion; 2014; 90(4):265-72. PubMed ID: 25591885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Branch-duct intraductal papillary mucinous neoplasm (IPMN): Are cyst volumetry and other novel imaging features able to improve malignancy prediction compared to well-established resection criteria?
    Pozzi Mucelli RM; Moro CF; Del Chiaro M; Valente R; Blomqvist L; Papanikolaou N; Löhr JM; Kartalis N
    Eur Radiol; 2022 Aug; 32(8):5144-5155. PubMed ID: 35275259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.